Centers for Disease Control and Prevention director Rochelle Walensky signed off on allowing Moderna and Pfizer COVID-19 shots for children as young as 6 months old on Saturday.
Why it matters: The shots could be in little arms as early as next week, as most states have already pre-ordered COVID vaccines for children under 5 in anticipation of federal authorization.
The pandemic hit millions of renters hard — especially people of color, individuals living with children and those living in the South, according to a new report from the Center on Budget and Policy Priorities (CBPP).
Why it matters: Rent reached an all-time high in recent months in large part due to the pandemic, which exacerbated existing inequities.
Florida Gov. Ron DeSantis will allow health care providers to order COVID-19 vaccines from a federal program for children between six months and 5 years old, the White House confirmed to Axios.
Why it matters: Florida is the only state that did not pre-order COVID vaccines for young children. DeSantis this week said the state was "affirmatively against the COVID vaccine for young kids."
Walgreens is getting into the clinical trial business, with the pharmacy giant saying Thursday it wants to change the patient experience and improve retention in sponsor-led drug research.
Why it matters: The chain's latest expansion into the health care delivery business is aimed at addressing the ongoing problem of low racial and ethnic diversity in clinical trials.
The Food and Drug Administration on Friday authorized both Pfizer-BioNTech and Moderna's COVID-19 shots for children as young as 6 months.
Why it matters: Some of the youngest Americans are now one step closer to being eligible to receive their vaccinations. Children under 5 are the last group without access to COVID vaccines.
Hopes for new Alzheimer's drugs took another disappointing turn Thursday, when Roche said an antibody therapy in a long-running trial didn't help people with a rare genetic condition that causes early-onset Alzheimer's.
The big picture: The news comes just weeks after the crash of Biogen's heavily touted Aduhelm — another Alzheimer's drug that targets a brain plaque called amyloid thought to contribute to the condition.
As the Supreme Court weighs the fate of Roe v. Wade,advocates and health care providers fear that cutting off access to abortion will lead to more pregnancy-related complications and deaths that disproportionately affect Black people.
